Max Bronstein - Executive Director of Government Affairs and Patient Advocacy @ Crinetics Pharmaceuticals

Overview

CB Rank (Person)

Max Bronstein is an Executive Director of Government Affairs and Patient Advocacy at Crinetics Pharmaceuticals.

Number of Current Jobs

Number of Past Jobs

is the

Executive Director of Government Affairs and Patient Advocacy

. Additionally,

has had

past job as the

Chief Advocacy & Science Policy Officer

Crinetics Pharmaceuticals Executive Director of Government Affairs and Patient AdvocacyMay 2023

Organization Name	Title At Company	Start Date	End Date
EveryLife Foundation for Rare Diseases	Chief Advocacy & Science Policy Officer	—	Jun 2017

Hub Name	CB Rank (Hub)
Western US Pharmaceutical Companies	15,171
West Coast Therapeutics Companies	22,410
Western US Therapeutics Companies	18,307
Pharmaceutical Public Companies With Less Than $10M in Revenue	60,982
West Coast Public Companies With Less Than $50M in Revenue	59,417
Adage Capital Management Portfolio Companies	76,975
California Pharmaceutical Companies	22,083
Vivo Capital Portfolio Companies	69,793
Biotechnology Public Companies With Less Than $10M in Revenue	39,665
Bain Capital Life Sciences Portfolio Companies	75,264